VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,369 | -29.0% | 15,192 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,838 | -85.0% | 15,192 | -76.4% | 0.00% | -50.0% |
| Q4 2021 | $125,553 | -28.8% | 64,386 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $176,418 | -13.0% | 64,386 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $202,816 | – | 64,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |